dokumendiregister.ee
Sissetulev dokumentAvalik

Infokiri

Terviseamet · 17. märts 2025
Viit
8-2/25/1945-1
Registreeritud
17. märts 2025
Dokumendi liik
Sissetulev dokument
Adressaat
ECDC respiratory viruses
Saabumis/saatmisviis
e-post
Funktsioon
8 Nakkushaiguste seire, ennetuse ja tõrje korraldamine
Sari
8-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus
Toimik
8-2/2025
Vastutaja
Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond)

Failid

Sisu (failidest)

Saatja: "ECDC respiratory viruses" <[email protected]> Teema: To NFPs and OCPs FOR ACTION: INFLVIRAGGR, NCOVAGGR and NCOVTEST to be discontinued Kuupäev: 2025-03-14 16:00 Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. To: National Focal Points for Viral Respiratory Diseases, Operational Contact Points for COVID-19, Influenza and SARI Cc: National Coordinators Dear colleagues, Thank you to all countries that have transition to the new integrated recordtypes in TESSy for respiratory surveillance data over the past months! We want to inform you that it will not be possible to report data beyond 2025-W14 to INFLVIRAGGR, NCOVAGGR and NCOVTEST. Data previously reported to these recordtypes for 2025-W15 and beyond will need to be reported to RESPIAGGR, RESPISEVERE and/or RESPISURV. For those countries that have not transitioned, please make sure to move reporting to RESPIAGGR, RESPISEVERE and/or RESPISURV as soon as possible. The European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe (WHO/Europe) continue to be available to assist in case you have any questions about the transition. Updating historic data in INFLVIRAGGR, NCOVAGGR and NCOVTEST will remain possible until mid-May. After mid-May, the historic data in the old recordtypes will be frozen and any historic updates would need to be made through the new recordtypes. Please do not hesitate to contact us at <mailto:[email protected]> [email protected] and [email protected] <mailto:[email protected]> with any questions or concerns. Kind regards, The WHO/Europe and ECDC Respiratory Virus Surveillance Teams Classified as ECDC NORMAL  Confidentiality Notice If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal. Classified as ECDC NORMAL
Allikas: Terviseamet dokumendiregister →